Results 21 to 30 of about 169,224 (213)

The miR-139-5p regulates proliferation of supratentorial paediatric low-grade gliomas by targeting the PI3K/AKT/mTORC1 signalling [PDF]

open access: yes, 2018
Paediatric low-grade gliomas (pLGGs) are a heterogeneous group of brain tumours associated with a high overall survival: however, they are prone to recur and supratentorial lesions are difficult to resect, being associated with high percentage of disease
Antonelli, Manila   +19 more
core   +1 more source

Efficient Prodrug Activator Gene Therapy by Retroviral Replicating Vectors Prolongs Survival in an Immune-Competent Intracerebral Glioma Model. [PDF]

open access: yes, 2020
Prodrug activator gene therapy mediated by murine leukemia virus (MLV)-based retroviral replicating vectors (RRV) was previously shown to be highly effective in killing glioma cells both in culture and in vivo.
Chang, Deching   +13 more
core   +2 more sources

Towards Development of a Standard Terminology of the World Health Organization Classification of Tumors of the Central Nervous System in the Turkish Language, and a Perspective on the Practical Implications of the WHO Classification for Low and Middle Income Countries

open access: yesTürk Patoloji Dergisi, 2022
In our manuscript, we propose a common terminology in the Turkish language for the newly adopted WHO classification of the CNS tumors, also known as the WHO CNS 5th edition. We also comment on the applicability of this new scheme in low and middle income
Figen SOYLEMEZOGLU   +8 more
doaj   +1 more source

Expression and tumor-promoting effects of caprin-1 in human glioma

open access: yesGlioma, 2018
Background: Cytoplasmic activation/proliferation-associated protein-1 (caprin-1) is a newly discovered RNA-binding protein and is now recognized as one of the putative oncogenes.
Li Zhang   +9 more
doaj   +1 more source

Noninvasive Classification of Glioma Subtypes Using Multiparametric MRI to Improve Deep Learning

open access: yesDiagnostics, 2022
Background: Deep learning (DL) methods can noninvasively predict glioma subtypes; however, there is no set paradigm for the selection of network structures and input data, including the image combination method, image processing strategy, type of numeric
Diaohan Xiong   +11 more
doaj   +1 more source

Tumor Therapy Mediated by Lentiviral Expression of shBcl-2 and S-TRAIL

open access: yesNeoplasia: An International Journal for Oncology Research, 2007
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) can selectively kill tumor cells and, in combination with other agents, could enhance tumor therapy.
Norman Kock   +3 more
doaj   +1 more source

Publication Landscape Analysis on Gliomas: How Much Has Been Done in the Past 25 Years?

open access: yesFrontiers in Oncology, 2020
Introduction: The body of glioma-related literature has grown significantly over the past 25 years. Despite this growth in the amount of published research, gliomas remain one of the most intransigent cancers. The purpose of this study was to analyze the
Chenzhe Feng   +6 more
doaj   +1 more source

Molecular and Genetic Determinants of Glioma Cell Invasion. [PDF]

open access: yes, 2017
A diffusely invasive nature is a major obstacle in treating a malignant brain tumor, "diffuse glioma", which prevents neurooncologists from surgically removing the tumor cells even in combination with chemotherapy and radiation.
Kato, Yoichiro   +4 more
core   +2 more sources

Clinical, radiologic, pathologic, and molecular characteristics of long-term survivors of diffuse intrinsic pontine glioma (DIPG): a collaborative report from the International and European Society for Pediatric Oncology DIPG registries [PDF]

open access: yes, 2018
Purpose Diffuse intrinsic pontine glioma (DIPG) is a brainstem malignancy with a median survival of < 1 year. The International and European Society for Pediatric Oncology DIPG Registries collaborated to compare clinical, radiologic, and ...
Antonelli, Manila   +73 more
core   +4 more sources

Immunocompetent murine models for the study of glioblastoma immunotherapy. [PDF]

open access: yes, 2014
Glioblastoma remains a lethal diagnosis with a 5-year survival rate of less than 10%. (NEJM 352:987-96, 2005) Although immunotherapy-based approaches are capable of inducing detectable immune responses against tumor-specific antigens, improvements in ...
Bloch, Orin   +9 more
core   +2 more sources

Home - About - Disclaimer - Privacy